Table 1.
Micro-RNAs as Diagnostic or Prognostic markers in FFPE Samples
| Cancer | Diagnostic miRs | Prognostic miRs | References |
|---|---|---|---|
| Head and Neck Squamous cell carcinoma | miR-16, -20a, -21, -106b, -142-3p, -155, -423, let-7i (up); miR-10a, -125b, -375 (down) |
miR-451 (up) | [47] |
| Breast cancer | miR-21(up); let-7a, miR-145, -205 (down) | [70] | |
| miR-21 (up) | [71] | ||
| miR-21, -155, -191, -196a (up); miR-125b, -221 (down) | [44] | ||
| Lung cancer | miR-21, -205 | [72] | |
| miR-16 (up) | [73] | ||
| Gastrointestinal Cancers | |||
| Gastric cancer | miR-106a (up) | [74] | |
| miR-31 (down) | [75] | ||
| miR-10b, -21, -223, -338 (up); miR-30a-5p, -126, let-7a (down) |
[37] | ||
| Pancreatic cancer | miR-452, -105, -127, -518a-2, -187, -30a-3p (up) | miR-196a-2 (up) | [76] |
| miR-21, -155 (up) | [77] | ||
| miR-21, -221, -222, let-7a (up) | [78] | ||
| miR-200c (down) | [79] | ||
| Gynecological Cancers | |||
| Cervical cancer | miR-9, -200a | [39] | |
| Ovarian cancer | miR-223 (up); miR-9 (down) | [80] | |
| miR-200a, -200b, -429 (down) | [81] | ||
| miR-23a, -27a (up) | [82] | ||
| miR-29b (up) | [83] | ||
| Prostate cancer | miR-125b (up) | [84] | |
| miR-15a, -16 (down) | [85] | ||
| miR-184 (up); miR-146a (down) | miR-184 (up) | [86] | |
| miR-203 (down) | [87] | ||
| miR-34c (down) | miR-34c (down) | [88] | |
| miR-221 (down) | [89] | ||